NCT02251093View on ClinicalTrials.gov

Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2016

Conditions
Candidiasis, Vulvovaginal
Interventions
DRUG

Lcr Regenerans

Dosage: 1 vaginal capsule per day Route of administration: intravaginal Treatment duration: One 21-day cycle

DRUG

Placebo

Dosage: 1 vaginal capsule per day Route of administration: intravaginal Treatment duration: One 21-day cycle

Trial Locations (1)

15130

Probionov, Aurillac

All Listed Sponsors
lead

Probionov

INDUSTRY

NCT02251093 - Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter